Editorial: T Cell Alterations in Adipose Tissue During Obesity, HIV, and Cancer D. E. Lewis; J. Lysaght; H. Wu Editorial: T Cell Alterations in Adipose Tissue During Obesity, HIV, and Cancer Front Immunol
Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity L. Lynch; D. O'Shea; D. C. Winter; J. Geoghegan; D. G. Doherty; C. O'Farrelly Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity Eur J Immunol
Acceptability of a Mobile Health Behavior Change Intervention for Cancer Survivors With Obesity or Overweight: Nested Mixed Methods Study Within a Randomized Controlled Trial J. M. Groarke; J. Richmond; J. Mc Sharry; A. Groarke; O. M. Harney; M. G. Kelly; J. C. Walsh Acceptability of a Mobile Health Behavior Change Intervention for Cancer Survivors With Obesity or Overweight: Nested Mixed Methods Study Within a Randomized Controlled Trial JMIR Mhealth Uhealth
The development of the metabolic syndrome and insulin resistance after adjuvant treatment for breast cancer E. M. Guinan; E. M. Connolly; L. A. Healy; P. A. Carroll; M. J. Kennedy; J. Hussey The development of the metabolic syndrome and insulin resistance after adjuvant treatment for breast cancer Cancer Nursing Insulin Resistance & Diabetes Metabolic Syndrome
Metastatic lung cancer presenting as gastric outlet obstruction: diagnosis and management with laparoscopic gastric bypass: a novel technique R. W. Gilbert; B. R. Bird; C. J. O'Boyle Metastatic lung cancer presenting as gastric outlet obstruction: diagnosis and management with laparoscopic gastric bypass: a novel technique BMJ Case Rep
Platelet-Derived Microparticles From Obese Individuals: Characterization of Number, Size, Proteomics, and Crosstalk With Cancer and Endothelial Cells R. Grande; M. Dovizio; S. Marcone; P. B. Szklanna; A. Bruno; H. A. Ebhardt; H. Cassidy; N. Á. F; A. Caprodossi; P. Lanuti; M. Marchisio; G. Mingrone; P. B. Maguire; P. Patrignani Platelet-Derived Microparticles From Obese Individuals: Characterization of Number, Size, Proteomics, and Crosstalk With Cancer and Endothelial Cells Front Pharmacol
Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma J. A. Elliott; J. V. Reynolds Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma Front Oncol Metabolic Syndrome
Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment N. Essa; F. O'Connell; A. Prina-Mello; J. O'Sullivan; S. Marcone Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment Cancer Lett
Extratumoral PD-1 blockade does not perpetuate obesity-associated inflammation in esophageal adenocarcinoma K. C. Galvin; M. J. Conroy; S. L. Doyle; M. R. Dunne; R. Fahey; E. Foley; K. E. O'Sullivan; D. G. Doherty; J. G. Geoghegan; N. Ravi; C. O'Farrelly; J. V. Reynolds; J. Lysaght Extratumoral PD-1 blockade does not perpetuate obesity-associated inflammation in esophageal adenocarcinoma Cancer Lett
Cancer, obesity and immunometabolism – Connecting the dots L. Dyck; L. Lynch Cancer, obesity and immunometabolism – Connecting the dots Cancer Lett